068270.KS - Celltrion, Inc.
NEXT EARNINGS:
May 8, 2026
EPS Est: $1216.07
|
Rev Est: $1.1T
Price:
--
--
Market Cap:
54.37T
Volume:
310,532
Avg Volume:
759,994
52 Week Range:
144615.39-251000
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.20
Last Dividend:
$750.00
Exchange:
KSC
Country:
KR
Employees:
2,391
IPO Date:
2005-07-19
EPS (TTM):
4466.05
P/E Ratio:
40.53
Revenue (TTM):
4.16T
Total Assets:
21.06T
Total Debt:
2.19T
Cash & Equiv:
996.43B
Rev Growth (5Y):
17.6%
EPS Growth (5Y):
6.4%
FCF Growth (5Y):
24.8%
ROCE:
6.5%
Debt/Equity:
0.13
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $1826.16 | $1734.32 | +5.3% | $1.3T | $1.3T | +3.6% |
| 2025-11-07 | $1483.32 | $1397.15 | +6.2% | $1.0T | $1.1T | -6.3% |
| 2025-07-21 | $277.41 | $817.71 | -66.1% | $961.5B | $1.0T | -4.0% |
| 2025-05-07 | $460.99 | $598.56 | -23.0% | $841.9B | $907.6B | -7.2% |
| 2025-02-27 | $1078.03 | $982.48 | +9.7% | $1.1T | $1.0T | +6.2% |
| 2024-11-08 | $415.22 | $862.88 | -51.9% | $881.9B | $983.6B | -10.3% |
| 2024-08-07 | $377.00 | $297.59 | +26.7% | $874.7B | $845.6B | +3.4% |
| 2024-05-09 | $108.00 | $593.73 | -81.8% | $737.0B | $733.1B | +0.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.16T | 3.56T | 2.18T | 2.28T | 1.89T | 1.85T | 1.13T | 982.07B | 949.08B | 670.58B | 603.41B | 471.05B |
| Net Income | 1.03T | 422.69B | 535.65B | 537.84B | 579.46B | 517.76B | 301.03B | 245.76B | 368.22B | 177.99B | 154.09B | 112.68B |
| EPS | 4466.05 | 1969.23 | 3442.31 | 3894.00 | 3663.00 | 3277.50 | 2084.07 | 1700.53 | 2550.83 | 1104.05 | 1046.64 | 827.63 |
| Total Assets | N/A | 21.06T | 19.92T | 5.89T | 5.67T | 5.02T | 3.86T | 3.50T | 3.29T | 3.02T | 2.75T | 2.32T |
| Total Debt | N/A | 2.19T | 1.89T | 792.33B | 744.36B | 774.40B | 495.37B | 516.56B | 640.92B | 678.94B | 795.86B | 845.45B |
| Cash & Equivalents | N/A | 996.43B | 564.61B | 551.19B | 1.19T | 684.29B | 546.14B | 410.55B | 419.21B | 268.41B | 149.93B | 108.75B |
| Operating Cash Flow | N/A | 901.87B | 537.16B | 863.53M | 911.16B | 350.75B | 473.99B | 364.79B | 485.98B | 250.89B | 77.57B | 145.16B |
| Free Cash Flow | N/A | 568.35B | 183.43B | (311.12B) | 589.59B | (190.65B) | 187.86B | 176.97B | 388.99B | 72.60B | (107.02B) | 9.77B |
| FCF per Share | N/A | 2619.07 | 1285.17 | -2252.84 | 4069.93 | -1317.97 | 1300.56 | 1224.56 | 2694.73 | 504.26 | -764.92 | 71.76 |
| Book Value | N/A | 17.44T | 16.98T | 4.14T | 3.92T | 3.31T | 2.76T | 2.49T | 2.29T | 2.05T | 1.69T | 1.25T |
| Cash & ST Investments | N/A | 1.14T | 757.50B | 594.46B | 1.22T | 698.33B | 627.82B | 532.18B | 557.92B | 274.17B | 155.93B | 138.90B |
| ROC Equity | N/A | 0.02 | 0.03 | 0.13 | 0.15 | 0.16 | 0.11 | 0.10 | 0.16 | 0.09 | 0.09 | 0.09 |